The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 340:1923-1924 June 17, 1999 Number 24
NextNext

An Unusual Cluster of Cases of Castleman's Disease during Highly Active Antiretroviral Therapy for AIDS

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: Castleman and coworkers first described a lymphatic hyperplasia now called Castleman's disease, which has two forms, the hyaline vascular type (found in 90 percent of cases) and the plasma-cell type (found in 10 percent).1,2 Patients may present with a multicentric lymphadenopathy and progressive systemic symptoms or with a more localized, indolent disease that can often be cured by local excision. The majority of patients with so-called multicentric Castleman's disease have the plasma-cell–rich variant with an interfollicular predominance of plasma cells on histologic analysis.2,3 Multicentric Castleman's disease is associated with infection with human herpesvirus 8 (HHV-8)4,5 and is . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.